https://www.selleckchem.com/pr....oducts/sorafenib.htm
. The non-anticoagulation group (n=37) showed a high recurrence rate (P0.01) compared with the anticoagulant group. This study showed that warfarin and edoxaban are equally effective in preventing VTE recurrence and bleeding. However, warfarin control in CAT patients presented some difficulties. This study also demonstrated the efficacy of anticoagulant drugs, compared with no anticoagulation, for CAT patients to prevent VTE recurrence. This study showed that warfarin and edoxaban are equally effective in preventing VTE recurren